31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
In the wake of the COVID-19 crisis, many companies will be facing significant financial difficulties...
Read More >
The Illinois Supreme Court’s recent decision in Restore Construction Company v. Board of Education ...
Read More >
Our comprehensive Guide to Doing Business in Australia, developed from the experience of our lawyers...
Read More >
On Oct. 13, 2019, New York City enacted Int. 136-A (the Law), expanding the employment protections o...
Read More >
This e-Book provides guidance for the I-9 process, covering topics including: -Procedures -Employee...
Read More >
In this update, we consider key statistics, trends, developments and highlights regarding U.K. publi...
Read More >